Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

HKG/2162 stock hub

HKG/2162 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HKG/2162is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

21.2B

Hong Kong Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

HKG/2162

In the news

Latest news · HKG/2162

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E42.4

P25 11.7P50 18.9P75 41.4

Trailing P/En/a

P25 10.7P50 17.9P75 38.5

ROE-19.9

P25 -14.7P50 2P75 9.4

ROIC-11.6

P25 -10.4P50 1.9P75 10.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HKG/2162 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

161

Groups with data

Currency

CNY

Showing 161 of 161 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Cayman Islands
Country code	HK
Employees	1,625
Employees Change	367%
Employees Change Percent	29.17
Enterprise value	HKD 19.9B
Exchange	Hong Kong Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Biotechnology
Isin	KYG5252B1023
Last refreshed	2026-05-10
Market cap	HKD 21.2B
Price	HKD 71.95
Price currency	HKD
Rev Per Employee	490,535.66x
Sector	Healthcare
Sic	2836
Symbol	hkg/2162
Website	https://www.keymedbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-2.74%
EV Earnings	-34.27x
EV/Sales	25.01x
Forward P/E	42.37x
P/B ratio	6.86x
P/S ratio	26.59x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-88.1%
EBITDA Margin	-77.62%
Gross margin	87.71%
Gross Profit	HKD 699.1M
Gross Profit Growth	-24.33%
Gross Profit Growth Q	-55.34%
Gross Profit Growth3 Y	123.79%
Gross Profit Growth5 Y	15.02%
Net Income	HKD -581.6M
Net Income Growth Years	1%
Pretax Margin	-72.69%
Profit Margin	-72.96%
Profit Per Employee	HKD -357,908
ROA	-9.88
Roa5y	-9.23
ROCE	-18.66
ROE	-19.91
Roe5y	-72.8
ROIC	-11.61

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	62.47%
Cagr3y	4.25%
EPS Growth Years	1
Revenue Growth	67.31x
Revenue Growth Q	-41.74x
Revenue Growth Years	3x
Revenue Growth3 Y	106.24x
Revenue Growth5 Y	16.97x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	HKD 0.18
Assets	HKD 4.7B
Cash	HKD 2.1B
Current Assets	HKD 2.8B
Current Liabilities	HKD 963M
Debt	HKD 877.5M
Debt Equity	HKD 0.28
Equity	HKD 3.1B
Interest Coverage	-37.32
Liabilities	HKD 1.6B
Long Term Assets	HKD 1.9B
Long Term Liabilities	HKD 642.3M
Net Cash	HKD 1.3B
Net Cash By Market Cap	HKD 5.96
Net Cash Growth	-19.05%
Net Debt Equity	HKD -0.41
Tangible Book Value	HKD 3.1B
Tangible Book Value Per Share	HKD 10.85
WACC	3.55

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.9
Inventory Turnover	0.55
Net Working Capital	HKD 202.2M
Quick ratio	2.42
Working Capital	HKD 1.8B
Working Capital Turnover	HKD 0.48

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-4.59%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	62.42%
200-day SMA	63.04
3Y total return	13.31%
50-day SMA	63.62
50-day SMA vs 200-day SMA	50over200
All Time High	82.85
All Time High Change	-13.16%
All Time High Date	2023-02-02
All Time Low	16.9
All Time Low Change	325.74%
All Time Low Date	2022-03-22
ATR	3.69
Beta	-0.11
Beta1y	1.14
Beta2y	0.61
Ch YTD	34.61
High	74.25
High52	81.85
High52 Date	2026-04-16
High52ch	-12.1%
Low	71.65
Low52	37.4
Low52 Date	2025-05-12
Low52ch	92.38%
Ma50ch	13.1%
Price vs 200-day SMA	14.14%
RSI	51.48
RSI Monthly	61.12
RSI Weekly	60.99
Sharpe ratio	1.06x
Sortino ratio	1.94
Total Return	-4.59%
Tr YTD	34.61
Tr1m	0.84%
Tr1w	-2.7%
Tr3m	31.06%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	HKD -702.2M
Operating margin	-88.1

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	219,448,084%
Shares Institutions	28.72%
Shares Out	294,599,566
Shares Qo Q	7.31%
Shares Yo Y	4.59%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	2,084,899.35x
Bv Per Share	10.88
Ch1m	0.84
Ch1w	-2.7
Ch1y	62.42
Ch3m	31.06
Ch3y	13.31
Ch6m	25.13
Change	-2.11%
Change From Open	-0.14
Close	73.5
Days Gap	-1.97
Depreciation Amortization	86,382,199.2
Dollar Volume	45,681,055
Earnings Date	2026-03-26
EBIT	HKD -702.2M
EBITDA	HKD -618.8M
EPS	HKD -2.12
F Score	1
Fiscal Year End	December
Founded	2,016
Income Tax	HKD 2.1M
Is Primary Listing	1
Last Earnings Date	2026-03-26
Last Report Date	2025-12-31
Ma150	61.09
Ma150ch	17.77%
Ma20	75.74
Ma20ch	-5%
Open	72.05
Position In Range	11.54
Ppne	1,496,233,933.6
Price Date	2026-05-08
Ptbv Ratio	6.89
Relative Volume	0.3x
Revenue	797,120,447x
Tax By Revenue	0.26x
Tr6m	25.13%
Volume	634,900

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does HKG/2162 pay a dividend?

Capital-return profile for this ticker.

Performance

HKG/2162 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns HKG/2162?

Insider, institutional, and short-interest positioning.

Institutional ownership

+28.7%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+4.6%

Negative means the company is buying back shares.

Technical

HKG/2162 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

51.5

Neutral momentum band

Price vs 200-day MA

+14.1%

50/200-day relationship not available

Beta (5Y)

-0.11

Less volatile than the market

Sharpe ratio

1.05

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HKG/2162

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hkg/2162 stock rating?

hkg/2162 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hkg/2162 analysis?

The full report lives at /stocks/hkg/2162/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hkg/2162?

The latest report frames hkg/2162 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hkg/2162 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.